Threshold-awareness in adaptive cancer therapy
PLOS Computational Biology · 2024
DOI: 10.1371/journal.pcbi.1012165 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2024. Verfasst von MingYi Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Applied Mathematics, Cornell University, Ithaca, New York, United States of America. Hauptthemen laut MEDLINE: Neoplasms, Algorithms, Stochastic Processes, Computational Biology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Division of Mathematical Sciences, Division of Cancer Epidemiology and Genetics, National Cancer Institute.
Abstract (Originalsprache)
Although adaptive cancer therapy shows promise in integrating evolutionary dynamics into treatment scheduling, the stochastic nature of cancer evolution has seldom been taken into account. Various sources of random perturbations can impact the evolution of heterogeneous tumors, making performance metrics of any treatment policy random as well. In this paper, we propose an efficient method for selecting optimal adaptive treatment policies under randomly evolving tumor dynamics. The goal is to improve the cumulative “cost” of treatment, a combination of the total amount of drugs used and the total treatment time. As this cost also becomes random in any stochastic setting, we maximize the probability of reaching the treatment goals (tumor stabilization or eradication) without exceeding a pre-specified cost threshold (or a “budget”). We use a novel Stochastic Optimal Control formulation and Dynamic Programming to find such “threshold-aware” optimal treatment policies. Our approach enables an efficient algorithm to compute these policies for a range of threshold values simultaneously. Compared to treatment plans shown to be optimal in a deterministic setting, the new “threshold-aware” policies significantly improve the chances of the therapy succeeding under the budget, which is correlated with a lower general drug usage. We illustrate this method using two specific examples, but our approach is far more general and provides a new tool for optimizing adaptive therapies based on a broad range of stochastic cancer models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Applied Mathematics, Cornell University, Ithaca, New York, United States of America.
- Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, Ohio, United States of America.
- Department of Mathematics and Center for Applied Mathematics, Cornell University, Ithaca, New York, United States of America.
ORCID-Profile: Alexander Vladimirsky
Förderung
- NCI NIH HHS
- Division of Mathematical Sciences
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- American Cancer Society
Zitieren
APA
Wang, M., Scott, J. G., & Vladimirsky, A. (2024). Threshold-awareness in adaptive cancer therapy. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1012165
Vancouver
Wang M, Scott JG, Vladimirsky A. Threshold-awareness in adaptive cancer therapy. PLOS Computational Biology. 2024. doi:10.1371/journal.pcbi.1012165
BibTeX
@article{Wang2024,
author = {Wang, MingYi and Scott, Jacob G and Vladimirsky, Alexander},
title = {Threshold-awareness in adaptive cancer therapy},
journal = {PLOS Computational Biology},
year = {2024},
doi = {10.1371/journal.pcbi.1012165}
}
EUVIMED